Zhu XZ - Search Results

1

[Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].

Zhu XZ, Wang LH, Ou GF, Zhou ZM, Chen DF, Xiao ZF, Feng QF, Zhang HX, Wang M, Yin WB. Zhu XZ, et al. Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):748-53. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396686 Chinese.

2

Association between plasma angiotensin-converting enzyme level and radiation pneumonitis.

Zhao L, Wang L, Ji W, Wang X, Zhu X, Feng Q, Yang W, Yin W. Zhao L, et al. Cytokine. 2007 Jan;37(1):71-5. doi: 10.1016/j.cyto.2007.02.019. Epub 2007 Apr 3. Cytokine. 2007. PMID: 17408964

3

Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.

Zhao L, Wang L, Ji W, Wang X, Zhu X, Hayman JA, Kalemkerian GP, Yang W, Brenner D, Lawrence TS, Kong FM. Zhao L, et al. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1385-90. doi: 10.1016/j.ijrobp.2008.10.065. Epub 2009 Feb 21. Int J Radiat Oncol Biol Phys. 2009. PMID: 19231104

4

A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.

Kong C, Guo WJ, Zha WW, Zhu XZ, Huang SF, Zhang YW, Xu JH, He X. Kong C, et al. Among authors: zhu xz. Lung Cancer. 2014 Apr;84(1):7-12. doi: 10.1016/j.lungcan.2014.01.015. Epub 2014 Jan 31. Lung Cancer. 2014. PMID: 24548340 Review.

5

Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer.

Kong C, Zhu X, Shi M, Wang L, Chen C, Tao H, Jiang N, Yan P, Zhao L, Song X, He X. Kong C, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):710-719. doi: 10.1016/j.ijrobp.2020.03.038. Epub 2020 Apr 7. Int J Radiat Oncol Biol Phys. 2020. PMID: 32275994 Clinical Trial.

6

T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.

Wu L, Zhu J, Rudqvist NP, Welsh J, Lee P, Liao Z, Xu T, Jiang M, Zhu X, Pan X, Li P, Zhou Z, He X, Yin R, Feng J. Wu L, et al. Front Immunol. 2021 Oct 18;12:719285. doi: 10.3389/fimmu.2021.719285. eCollection 2021. Front Immunol. 2021. PMID: 34733273 Free PMC article.

7

Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016.

Wang X, Liang F, Wang X, Wu Y, Wang D, Cheng Y, Li J, Zhang Y, Sun B, Lin Y, Yu D, Ge X, Shen J, Yao G, Wu L, Zhang J, Jiang W, Bi N, Yu Z, Wang Q, Yang Z, Sun X, Chen J, Cao J, Ge H, Wang J, Zhu X, Jiang H, Zhao Y, Zhao K, Wang L. Wang X, et al. J Natl Cancer Cent. 2023 May 10;3(2):150-158. doi: 10.1016/j.jncc.2023.05.001. eCollection 2023 Jun. J Natl Cancer Cent. 2023. PMID: 39035729 Free PMC article.

8

Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience.

Song X, Zhao L, Jiang N, Ding N, Zong D, Zhang N, Wang D, Wen J, He X, Kong C, Zhu X. Song X, et al. Curr Probl Cancer. 2023 Jun;47(3):100956. doi: 10.1016/j.currproblcancer.2023.100956. Epub 2023 Mar 11. Curr Probl Cancer. 2023. PMID: 36966677

9

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.

Kong C, Yu S, Qian P, Song X, Wen J, Jiang M, Zhu J, Xu J, Zhao L, Guo Z, Wu J, He X, Zhu X. Kong C, et al. Front Oncol. 2023 Sep 12;13:1169333. doi: 10.3389/fonc.2023.1169333. eCollection 2023. Front Oncol. 2023. PMID: 37771446 Free PMC article.

10

Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial.

Jiang N, Zhang J, Guo Z, Wu Y, Zhao L, Kong C, Song X, Gu L, Zhao Y, Li S, He X, Ren B, Zhu X, Jiang M. Jiang N, et al. J Immunother Cancer. 2024 Jan 9;12(1):e008229. doi: 10.1136/jitc-2023-008229. J Immunother Cancer. 2024. PMID: 38199609 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page